ArticleInternational journal of chronic obstructive pulmonary disease2026
Predictive Value of SAPS II for 28-Day All-Cause Mortality in AECOPD Patients Admitted to the ICU.
Article in International journal of chronic obstructive pulmonary disease, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The Simplified Acute Physiology Score II (SAPS II), which incorporates 12 physiological variables along with age, admission type and chronic health conditions, is widely used for assessing illness severity and predicting mortality risk in critically ill patients. However, its prognostic value in patients with acute exacerbation of chronic obstructive pulmonary disease (AECOPD) remains unclear. Methods: A total of 1087 eligible AECOPD patients admitted to intensive care unit (ICU) were included from the Medical Information Mart for Intensive Care IV database. The clinical characteristics and 28-day all-cause mortality of these patients were collected. Results: SAPS II was significantly higher in non-survivors than in survivors among the AECOPD patients admitted to ICU. For predicting 28-day all-cause mortality, SAPS II showed superior discriminative ability compared to the scores of Sequential Organ Failure Assessment, Oxford Acute Severity of Illness Score, and Logistic Organ Dysfunction System. The combination of SAPS II with these scoring systems did not significantly enhance the predictive value. Kaplan-Meier survival analysis identified SAPS II ≥ 37 as a significant cut-off value, with patients scoring above this threshold showing a significantly decreased 28-day cumulative survival rate. Cox regression confirmed SAPS II ≥ 37 as an independent mortality predictor. Restricted cubic spline analysis revealed a linear increase in 28-day all-cause mortality risk with elevated SAPS II. Subgroup analysis revealed that the association between SAPS II and mortality risk remained consistent across the most subgroups except for coronary heart disease. Conclusion: Our findings demonstrate that SAPS II is a significant predictor of 28-day all-cause mortality in AECOPD patients admitted to the ICU, with a score ≥ 37 serving as a robust indicator of poor clinical prognosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.